- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-6405
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
HIV vaccine research in Canada ; volume:14 ; number:1 ; day:12 ; month:9 ; year:2017 ; pages:1-3 ; date:12.2017
AIDS research and therapy ; 14, Heft 1 (12.9.2017), 1-3, 12.2017
- Schlagwort
-
Allergie
Immunkrankheit
- Urheber
-
Shattock, Robin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12981-017-0181-8
- URN
-
urn:nbn:de:1111-201711109724
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shattock, Robin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Under consent: participation of people with HIV in an Ebola vaccine trial in Canada
HIV Vaccine Research Agenda: Perspectives of an HVTN Site Investigator
HIV prevention by vaccine
Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
Correction to: Under consent: participation of people with HIV in an Ebola vaccine trial in Canada
Research priorities in HIV, aging and rehabilitation: building on a framework with the Canada-International HIV and Rehabilitation Research Collaborative
Prospecting for an HIV vaccine
Research priorities for rehabilitation and aging with HIV: a framework from the Canada-International HIV and Rehabilitation Research Collaborative (CIHRRC)
P15-18. Behavioral and social science in HIV vaccine clinical research: workshop recommendations
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
Nanoparticles for HIV-1 vaccine delivery
HIV-1 vaccine immunogen design strategies
Under consent: participation of people with HIV in an Ebola vaccine trial in Canada
HIV Vaccine Research Agenda: Perspectives of an HVTN Site Investigator
HIV prevention by vaccine
Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
Correction to: Under consent: participation of people with HIV in an Ebola vaccine trial in Canada
Research priorities in HIV, aging and rehabilitation: building on a framework with the Canada-International HIV and Rehabilitation Research Collaborative
Prospecting for an HIV vaccine
Research priorities for rehabilitation and aging with HIV: a framework from the Canada-International HIV and Rehabilitation Research Collaborative (CIHRRC)
P15-18. Behavioral and social science in HIV vaccine clinical research: workshop recommendations
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
Nanoparticles for HIV-1 vaccine delivery
HIV-1 vaccine immunogen design strategies
Under consent: participation of people with HIV in an Ebola vaccine trial in Canada
HIV Vaccine Research Agenda: Perspectives of an HVTN Site Investigator
HIV prevention by vaccine
Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
Correction to: Under consent: participation of people with HIV in an Ebola vaccine trial in Canada
Research priorities in HIV, aging and rehabilitation: building on a framework with the Canada-International HIV and Rehabilitation Research Collaborative
Prospecting for an HIV vaccine
Research priorities for rehabilitation and aging with HIV: a framework from the Canada-International HIV and Rehabilitation Research Collaborative (CIHRRC)
P15-18. Behavioral and social science in HIV vaccine clinical research: workshop recommendations
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
Nanoparticles for HIV-1 vaccine delivery